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An alternate possibility is that Otx1 regulates the re- New work, including a paper by Cummings et al. (1999)
in this issue of Neuron, shows that large inclusions aresponsiveness of cortical projection neurons to signals
at least not required for expanded polyglutamine pathol-that control the elimination of inappropriate axon termi-
ogy and raise new questions about pathological mecha-nals. For instance, elimination of visual cortical axons
nisms in this group of disorders.from the spinal cord might involve expression of a recep-
Recent evidence suggests that large inclusions aretor to a repulsive axon guidance cue, or loss of a receptor
not required for toxicity in polyglutamine repeat expan-to a trophic factor. Positive or negative regulation of
sions. First, cells from SCA2 patients reportedly lackthese receptors by Otx1 could allow the transcription
such inclusions (Huynh et al., 1999). Second, preventingfactor to exert an important regulatory influence on the
inclusions through protein engineering does not blockrefinement of axonal projections. While this is an attrac-
polyglutamine-dependent pathology induced by ex-tive model, it should be noted that Otx1 expression can-
panded ataxin-1 in mice (Klement et al., 1998) or ex-not be the sole determinant of whether certain subcorti-
panded huntingtin in transfected neuronal cultures (Sau-cal projections are eliminated. In addition to visual
dou et al., 1998). Both normal huntingtin and ataxin-1cortex, Otx1 is expressed in other cortical areas, such
are degraded by a ubiquitin±proteasome pathway, inas motor cortex, that maintain projections to the spinal
which addition of ubiquitin by specific ligases marks thecord. Elimination of exuberant axon projections by visual
protein for degradation by proteasome. NIs from bothcortical neurons must therefore involve additional mech-
patient materials and animal models show high ubiquitinanisms. Understanding the mechanisms by which Otx1
content and colocalization of proteasomes. Cummingsregulates region-specific pruning of subcortical projec-
et al. (1999) show that although wild-type and expandedtions should provide valuable insight into the problem
ataxin-1 are similarly ubiquitinated, the expanded pro-of cortical connectivity.
tein is selectively resistant to degradation and forms
ubiquitin-positive, detergent-insoluble aggregates. Inhi-
Anirvan Ghosh bition of proteasome activity with b-lactone increases
Department of Neuroscience the frequency of ubiquitin-positive NIs in HeLa cells
Johns Hopkins University School of Medicine transfected with expanded ataxin-1, suggesting that pro-
Baltimore, Maryland 21205 teasomes either degrade the expanded ataxin-1 mono-
mers before they form large aggregates or degrade the
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Acampora, D., Mazan, S., Avantaggiato, V., Barone, P., Tuorto, F., celerates the pathology associated with expanded
Lallemand, Y., Brulet, P., and Simeone, A. (1996). Nat. Genet. 14, ataxin-1.218±222.
The genetic interaction between expanded ataxin-1
Frantz, G.D., Weinmann, J.M., Levin, M.E., and McConnell, S.K.
and E6-AP raises interesting questions and places new(1994). J. Neurosci. 14, 5725±5740.
constraints on models for the mechanism of polygluta-Simeone, A., Acampora, D., Gulisano, M., Stornaiuolo, A., and Bonci-
mine-induced neurodegeneration. E6-AP is encoded bynelli, E. (1992). Nature 358, 687±690.
an imprinted gene, Ube3a, implicated in the mental re-Stanfield, B.B., and O'Leary, D.D.M. (1985). J. Comp. Neurol. 238,
tardation and other neurological features of Angelman236±248.
syndrome. Loss of the maternal copy of Ube3a in miceStanfield, B.B., O'Leary, D.D.M., and Fricks, C. (1982). Nature 298,
results in developmental and cognitive defects reminis-371±373.
cent of some features of Angelman syndrome and al-Weimann, J.M., Zhang, Y.A., Levin, M.E., Devine, W.P., Brulet, P.,
tered turnover of p53 protein, but no overt cellular pa-and McConnell, S.K. (1999). Neuron 24, this issue, 819±831.
thology (Jiang et al., 1998). In Cummings et al. (1999),
transgenic mice expressing an expanded allele of
ataxin-1 (line B05) that lack maternal Ube3a expression
(Ube3a(m2/p1)) show much more rapid onset of SCA1-like
pathology than transgenic mice that express Ube3a.Intranuclear Inclusions and the However, it is unclear whether ataxin-1 is a direct tar-
Ubiquitin±Proteasome Pathway: get of E6-AP. Indeed, ataxin-1 is polyubiquitinated in
Ube3a(m2/p1) mice. These results could be interpretedDigestion of a Red Herring?
several ways. The least interesting interpretation is that
E6-AP deficiency may simply lower the threshold for
cellular pathology initiated by the expanded ataxin-1 in
Neuronal intranuclear inclusions (NIs) are ubiquitin-posi- a relatively nonspecific manner: sick plus sick equals
tive protein aggregates that have recently been de- sicker. Alternatively, E6-AP may directly ubiquitinate
scribed as a common ultrastructural feature of several ataxin-1 or an essential cofactor for initiating pathology.
neurodegenerative polyglutamine repeat expansion dis- Ataxin-1 or its cofactor may be ubiquitinated by alterna-
orders, including Huntington's disease and the spino- tive ligases in the absence of E6-AP, but the alternative
cerebellar ataxias (SCAs). Some early reports specu- use of isozymes may alter the kinetics of ubiquitination
lated that formation of such inclusions might be the or its coupling (by spatial or association constraints) to
key toxic event in this group of disorders. However, proteasomal degradation.
the pathological role of NIs has been controversial. Are Most of the recent data, including those in Cummings
these inclusions a proximate cause of cellular pathology, et al. (1999), argue that formation of large intranuclear
inclusions is not the main cellular insult in expandeda protective reaction to it, or entirely beside the point?
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nuclear proteins with regulatory functions (CBP, TATA-
BP, and EYA) have been observed in coaggregates with
expanded polyglutamines in model systems (Perez et
al., 1998; Kazantsev et al., 1999). Ubiquitin-mediated
degradation (or self-aggregation) of expanded ataxin-1
could limit its ability to bind such proteins.
A feature of both models is that neurotoxicity should
roughly correspond to the available surface area of the
misfolded and/or aggregated protein. This agrees well
with the observation that disruption of NIs can increase
toxicity. Thus, any treatment that partially disrupts the
formation or maintenance of inclusions without reducing
the mass of constituent protein would be expected to
exacerbate the disease. The most promising therapeutic
targets might therefore be misfolded protein or compo-
nents of regulatory pathways disrupted by expanded
polyglutamine repeats rather than the protein aggre-
gates themselves. However, it remains to be seen
whether such regulatory pathways can be identified and
whether this kettle of herring will at last satisfy the palate.
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In Model 2, expanded polyglutamine proteins bind
other proteins necessary for cell function into a nonpro- Synaptic vesicles are the key organelles in neurotrans-
ductive complex, disrupting the balance of key cell regu- mitter release from nerve cells. Due to the ideal biochem-
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